Top-News
  • Depot
  • Watchlist
  • Glocke
  • Handeln

    • UCB News

    133,68 $ +8,68% +10,68 $
    In : 125,24 € | 26.04.24 17:27:02 Nasdaq OTC Other aktualisieren | Orderbuch | Mehr Kurse »
    WKN: 852738
    ISIN: BE0003739530
    US-Symbol: UCBJF
    Typ: Aktie
    Werbung
    Weiter aufwärts?
    Long Hebel 6,04
    ME92QW

    UCB News

    22.03.24 - GlobeNewswire
    UCB Convening Notice to the General Meeting of the Shareholders 2024
    CONVENING NOTICE TO THE GENERAL MEETING OF SHAREHOLDERS
    28.02.24 - wallstreet:online Zentralredaktion
    Was heute wichtig wird: Frische Zahlen vom BVB, Salesforce, Uniper und Apple hält HV ab
    Gut geplant in den Tag. Mit dem wO-​Tagesausblick haben Sie die wichtigsten Termine im Blick und starten bestens vorbereitet in den neuen Handelstag.Unternehmenstermine ...
    24.03.23 - GlobeNewswire
    UCB Convening Notice to the General Meeting of theShareholders 2023
    CONVENING NOTICE TO THE GENERAL MEETING OF SHAREHOLDERS The Board of Directors invites the shareholders for the general meeting of shareholders (the “ General ...
    25.03.22 - GlobeNewswire
    UCB SA/NV - CONVENING NOTICE TO THE GENERAL MEETING OF SHAREHOLDERS 2022
    *** Unofficial English translation – For convenience purposes only ***
    19.01.22 - Der Aktionär
    Zogenix‑Aktie schießt hoch: UCB schlägt zu – 72 Prozent Aufschlag
    02.12.21 - dpa-AFX
    Novartis und belgische UCB entwickeln gemeinsam Parkinson-Therapien
    Novartis hat sich mit der belgischen UCB zusammengetan, um die Forschung an möglichen Therapien der Parkinson-​Krankheit voranzutreiben. Dies teilte der Pharmakonzern am ...
    19.10.21 - Börse Online
    Innovationsaktie der Woche: UCB - Solides Wachstum, starke Innovation und Aktie vor einer wichtigen Marke
    Der belgische Pharmakonzern hat seine Innovationskraft in den vergangenen 3 Jahren stetig gesteigert, genauso wie Umsätze und Gewinne. Jetzt steht die Aktie vor einer wichtigen ...
    22.07.21 - Payoff
    UCB - belgischer Blue Chip erwacht
    Die Aktien des belgischen Pharma- und Biotechnologieunternehmen UCB vermochten im Juni, den Abwärtstrend nach oben zu durchbrechen und befinden sich seither im ...
    26.03.21 - GlobeNewswire
    UCB SA/NV - Convening notice annual shareholders meeting
    *** Unofficial English translation – For convenience purposes only ***
    29.07.20 - PR Newswire
    UCB enters into collaboration with Roche to develop antibody treatment for people living with Alzheimer's Disease
    UCB enters into collaboration with Roche to develop antibody treatment for people living with Alzheimer's Disease PR Newswire
    29.07.20 - PR Newswire
    UCB enters into collaboration with Roche to develop antibody treatment for people living with Alzheimer's Disease
    UCB enters into collaboration with Roche to develop antibody treatment for people living with Alzheimer's Disease PR Newswire
    27.07.20 - PR Newswire
    UCB Half Year Report 2020
    UCB Half Year Report 2020 UCB's resilient product portfolio drives continued company growth PR Newswire
    27.07.20 - PR Newswire
    UCB Half Year Report 2020
    UCB Half Year Report 2020 PR Newswire
    05.06.20 - PR Newswire
    UCB Acquires Engage Therapeutics: Staccato® Alprazolam - A potential Solution for Acute On-demand Seizure Management for People Living With Epilepsy
    UCB Acquires Engage Therapeutics: Staccato® Alprazolam - A potential Solution for Acute On-demand Seizure Management for People Living With Epilepsy - Underlines UCB's ...
    05.06.20 - PR Newswire
    UCB Acquires Engage Therapeutics: Staccato® Alprazolam - A potential Solution for Acute On-demand Seizure Management for People Living With Epilepsy
    UCB Acquires Engage Therapeutics: Staccato® Alprazolam - A potential Solution for Acute On-demand Seizure Management for People Living With Epilepsy PR Newswire
    01.04.20 - PR Newswire
    ADVANZ PHARMA Corp. Limited Closes Acquisition of the Rights to a Portfolio of Alprostadil Products from UCB S.A. for $83 Million
    ADVANZ PHARMA Corp. Limited Closes Acquisition of the Rights to a Portfolio of Alprostadil Products from UCB S.A. for $83 Million PR Newswire
    27.03.20 - GlobeNewswire
    UCB SA/NV : Convening notice to the general meeting of shareholders
    *** Unofficial English translation – For convenience purposes only ***  UCB SA/NV - Public Limited Liability Company Allée de la Recherche 60, 1070 Brussels Enterprise nr. ...
    06.03.20 - PR Newswire
    ADVANZ PHARMA Corp. Limited Announces Definitive Agreement to Acquire The Rights To A Portfolio Of Alprostadil Products From UCB S.A. For Approximately $84 Million
    ADVANZ PHARMA Corp. Limited Announces Definitive Agreement to Acquire The Rights To A Portfolio Of Alprostadil Products From UCB S.A. For Approximately $84 Million PR ...
    12.12.19 - PR Newswire
    UCB: Osteoporose Patientinnen sind der Meinung, die Gesundheits-behörden würden ihre Krankheit vernachlässigen und zurückstufen
    UCB: Osteoporose Patientinnen sind der Meinung, die Gesundheits-​behörden würden ihre Krankheit vernachlässigen und zurückstufen PR Newswire
    12.12.19 - PR Newswire
    UCB: Osteoporosis Patients Believe Their Condition is Neglected and Deprioritised by Healthcare Authorities
    UCB: Osteoporosis Patients Believe Their Condition is Neglected and Deprioritised by Healthcare Authorities PR Newswire

    Newssuche

    Videos

    newspaper
    30.04.24 -9,41%
    Technical Trading: Sojabohnen Long bis Juli
    Sojabohnen Long Typ: Turbo Open End WKN: VX41AH Hebel: 5 Laufzeit: OpenEnd Einstieg: Market ... Mehr »